Rituxan

Made by

• Bayer
• Zenyaku Kogyo

Active Ingredient

Rituximab

Prospectus

Approval date

2008/1/25

Treats

• Nephrotic syndrome
• Burkitt lymphoma
• Mantle cell lymphoma
• Lymphoplasmacytic lymphoma
• Granulomatosis with polyangiitis, Wegener granulomatosis
• Chronic lymphocytic leukemia
• Hairy cell leukemia
• Follicular lymphoma
• Immune thrombocytopenia, Autoimmune thrombocytopenic purpura
• Microscopic polyangiitis

Dosages

• Rituxan Intravenous Infusion - 27215円／瓶

• Rituxan Intravenous Infusion - 132999円／瓶

• Rituxan Intravenous Infusion - 27215円／瓶

• Rituxan Intravenous Infusion - 132999円／瓶

• Rituxan Intravenous Infusion - 27215円／瓶

• Rituxan Intravenous Infusion - 132999円／瓶

• Rituxan Intravenous Infusion - 27215円／瓶

• Rituxan Intravenous Infusion - 132999円／瓶